Wednesday, July 22, 2020

This Biotech Business Won't Let Cost Get in the Way of a Covid Cure

Synthetic gene manufacturer ATUM turned down venture capital. That's why it's free to do whatever it takes to fight Covid-19.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)